Fig. 3.
WT1 expression levels in PBMCs from patients with hematopoietic malignancies.
WT1 expression level in K562 leukemic cells was defined as 1.0 and the WT1 expression level in the sample was relatively shown compared to that in K562 cells. WT1 expression levels were measured in 56 of 73 patients.